Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Marie Dutreix, Sylvain Thierry et al.|Clinical Cancer Research|2016Cited by 42
Data from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Marie Dutreix, Sylvain Thierry et al.|Unknown|2023Cited by 0
Supplementary figure S2 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Marie Dutreix, Sylvain Thierry et al.|Unknown|2023Cited by 0
Supplementary figure S1 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Marie Dutreix, Sylvain Thierry et al.|Unknown|2023Cited by 0
Supplementary figure S3 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Marie Dutreix, Sylvain Thierry et al.|Unknown|2023Cited by 0